(Q44335950)

2 December 2017

Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal (English)

1 reference

2 December 2017

0 references

4

1 reference

2 December 2017

G A Higgins

1

1 reference

PubMed ID

1839177

2 December 2017

P Nguyen

series ordinal

2

1 reference

PubMed ID

1839177

2 December 2017

N Joharchi

series ordinal

3

1 reference

2 December 2017

1 January 1991

1 reference

2 December 2017

1 reference

2 December 2017

105

1 reference

2 December 2017

3

1 reference

2 December 2017

322-328

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02244425

2 December 2017

0 references

cites work

Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.

1 reference

https://api.crossref.org/works/10.1007%2FBF02244425

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244425

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244425

5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244425

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244425

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244425

Classically conditioned responses in opioid and cocaine dependence: a role in relapse?

21 January 2018

1 reference

12 December 2020

Effects of diazepam on cognitive processes in normal subjects

1 reference

12 December 2020

Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

1 reference

12 December 2020

Drug reinforcement studied by the use of place conditioning in rat

1 reference

12 December 2020

Enduring effects of morphine pellets revealed by conditioned taste aversion

1 reference

12 December 2020

Serotonin participation in gut withdrawal from opiates

1 reference

12 December 2020

Animal models of drug withdrawal symptoms

1 reference

12 December 2020

Quantitative aspects of precipitated abstinence in morphine-dependent rats

1 reference

12 December 2020

Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various br

1 reference

12 December 2020

Gepirone in anxiety: a pilot study.

1 reference

12 December 2020

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

1 reference

12 December 2020

Association of [3H]zacopride with 5-HT3 binding sites

1 reference

12 December 2020

Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species

1 reference

12 December 2020

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

1 reference

12 December 2020

Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats

1 reference

12 December 2020

Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats.

1 reference

12 December 2020

The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.

1 reference

12 December 2020

Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal

1 reference

12 December 2020

Effects of lorazepam on memory, attention and sedation in man.

1 reference

12 December 2020

Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

1 reference

12 December 2020

Aversive properties of opiate withdrawal studied in rats.

1 reference

12 December 2020

5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone

1 reference

12 December 2020

Sensitivities of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve-vas deferens of the guinea pig after chronic morphine pellet implantation.

1 reference

12 December 2020

Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea-pig

1 reference

12 December 2020

Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm

1 reference

12 December 2020

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.

1 reference

12 December 2020

Captopril and capsaicin modify opioid withdrawal in the morphine-dependent rat.

1 reference

12 December 2020

Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence

1 reference

12 December 2020

The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.

1 reference

12 December 2020

Drug anticipation and the treatment of dependence.

1 reference

12 December 2020

Clinical pharmacology and therapeutics of benzodiazepines

1 reference

12 December 2020

Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

1 reference

12 December 2020

Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat.

1 reference

12 December 2020

Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.

1 reference

12 December 2020

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

1 reference

12 December 2020

The neurobiology of craving: implications for the understanding and treatment of addiction

1 reference

12 December 2020

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244425

1 reference

2 December 2017

1 reference

PubMed ID

1839177